[半胱氨酰白三烯：哮喘中的重要介质] - Suppr

Suppr

超能文献

[Cysteinyl-leukotrienes: important mediators in asthma].

作者信息

Louis R, Neven I, Quadvlieg V, Bettiol J, Radermecker M

机构信息

Service de Pneumologie, Université de Liège.

出版信息

Rev Med Liege. 1997 Sep;52(9):598-602.

PMID:9441344

Abstract

摘要

相似文献

[Cysteinyl-leukotrienes: important mediators in asthma].

Rev Med Liege. 1997 Sep;52(9):598-602.

Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma.

Allergy. 2001;56 Suppl 66:7-11. doi: 10.1034/j.1398-9995.56.s66.2.x.

Cysteinyl leukotrienes in asthma: old mediators up to new tricks.

Trends Pharmacol Sci. 1995 Sep;16(9):304-9. doi: 10.1016/s0165-6147(00)89059-8.

Cysteinyl leukotriene interactions with other mediators and with glucocorticosteroids during airway inflammation.

J Allergy Clin Immunol. 2003 Jan;111(1 Suppl):S37-42; discussion S43-8. doi: 10.1067/mai.2003.23.

Introduction: the anti-inflammatory role of cysteinyl leukotriene receptor antagonists in asthma.

J Allergy Clin Immunol. 2003 Jan;111(1 Suppl):S1-4. doi: 10.1067/mai.2003.107.

[New developments in asthma therapy: how do individual leukotriene antagonists work?].

Praxis (Bern 1994). 1998 Feb 18;87(8):271-5.

Leukotrienes in respiratory disease.

Paediatr Respir Rev. 2001 Sep;2(3):238-44. doi: 10.1053/prrv.2001.0146.

Inflammatory cells in asthma: mechanisms and implications for therapy.

J Allergy Clin Immunol. 2003 Jan;111(1 Suppl):S5-S12; discussion S12-7. doi: 10.1067/mai.2003.22.

[Status of leukotrienes in the pathophysiology of asthma. Necessity for antileukotrienes treatment].

Pneumonol Alergol Pol. 2010;78(1):68-73.

Treatment of aspirin-intolerant asthma with antileukotrienes.

Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 2):S137-41. doi: 10.1164/ajrccm.161.supplement_1.ltta-27.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

[Cysteinyl-leukotrienes: important mediators in asthma].

作者信息

Louis R, Neven I, Quadvlieg V, Bettiol J, Radermecker M

机构信息

Service de Pneumologie, Université de Liège.

出版信息

Rev Med Liege. 1997 Sep;52(9):598-602.

PMID:9441344

Abstract

摘要

相似文献

[Cysteinyl-leukotrienes: important mediators in asthma].

Rev Med Liege. 1997 Sep;52(9):598-602.

Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma.

Allergy. 2001;56 Suppl 66:7-11. doi: 10.1034/j.1398-9995.56.s66.2.x.

Cysteinyl leukotrienes in asthma: old mediators up to new tricks.

Trends Pharmacol Sci. 1995 Sep;16(9):304-9. doi: 10.1016/s0165-6147(00)89059-8.

Cysteinyl leukotriene interactions with other mediators and with glucocorticosteroids during airway inflammation.

J Allergy Clin Immunol. 2003 Jan;111(1 Suppl):S37-42; discussion S43-8. doi: 10.1067/mai.2003.23.

Introduction: the anti-inflammatory role of cysteinyl leukotriene receptor antagonists in asthma.

J Allergy Clin Immunol. 2003 Jan;111(1 Suppl):S1-4. doi: 10.1067/mai.2003.107.

[New developments in asthma therapy: how do individual leukotriene antagonists work?].

Praxis (Bern 1994). 1998 Feb 18;87(8):271-5.

Leukotrienes in respiratory disease.

Paediatr Respir Rev. 2001 Sep;2(3):238-44. doi: 10.1053/prrv.2001.0146.

Inflammatory cells in asthma: mechanisms and implications for therapy.

J Allergy Clin Immunol. 2003 Jan;111(1 Suppl):S5-S12; discussion S12-7. doi: 10.1067/mai.2003.22.

[Status of leukotrienes in the pathophysiology of asthma. Necessity for antileukotrienes treatment].

Pneumonol Alergol Pol. 2010;78(1):68-73.

Treatment of aspirin-intolerant asthma with antileukotrienes.

Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 2):S137-41. doi: 10.1164/ajrccm.161.supplement_1.ltta-27.